STUDY OF THE COMBINATION OF RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VELCADE, AND PREDNISONE OR RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA: